Liu B, Yasunaga J, Liang Y, Zhou R, Yang S, Yuan X
Proc Natl Acad Sci U S A. 2025; 122(8):e2416412122.
PMID: 39982744
PMC: 11874535.
DOI: 10.1073/pnas.2416412122.
King E, Panfil A
Viruses. 2025; 17(1).
PMID: 39861913
PMC: 11769288.
DOI: 10.3390/v17010124.
Yeo B, Lee W, Mahmud R, Tan G, Wahid M, Cheah Y
World J Oncol. 2025; 16(1):1-15.
PMID: 39850528
PMC: 11750751.
DOI: 10.14740/wjon1955.
Mizuike J, Suzuki K, Tosaka S, Kuze Y, Kobayashi S, Nakashima M
Cancer Sci. 2024; 116(2):513-523.
PMID: 39561277
PMC: 11786301.
DOI: 10.1111/cas.16388.
Nwabo Kamdje A, Dongmo Fogang H, Mimche P
Front Mol Med. 2024; 4:1426454.
PMID: 39308891
PMC: 11412843.
DOI: 10.3389/fmmed.2024.1426454.
The noncanonical NFκB pathway: Regulatory mechanisms in health and disease.
Rodriguez B, Huang H, Chia J, Hoffmann A
WIREs Mech Dis. 2024; 16(6):e1646.
PMID: 38634218
PMC: 11486840.
DOI: 10.1002/wsbm.1646.
MicroRNAs and long non-coding RNAs during transcriptional regulation and latency of HIV and HTLV.
Alpuche-Lazcano S, Scarborough R, Gatignol A
Retrovirology. 2024; 21(1):5.
PMID: 38424561
PMC: 10905857.
DOI: 10.1186/s12977-024-00637-y.
Mechanisms of action and resistance in histone methylation-targeted therapy.
Yamagishi M, Kuze Y, Kobayashi S, Nakashima M, Morishima S, Kawamata T
Nature. 2024; 627(8002):221-228.
PMID: 38383791
PMC: 10917674.
DOI: 10.1038/s41586-024-07103-x.
Upregulation of Enhancer of Zeste Homolog 2 (EZH2) with Associated pERK Co-Expression and PRC2 Complex Protein SUZ12 Correlation in Adult T-Cell Leukemia/Lymphoma.
Chai J, Choudhuri J, Gong J, Wang Y, Tian X
Cancers (Basel). 2024; 16(3).
PMID: 38339397
PMC: 10854612.
DOI: 10.3390/cancers16030646.
The TGFβ2-Snail1-miRNA Circuitry is Critical for the Development of Aggressive Functions in Breast Cancer.
Luo L, Xu N, Fan W, Wu Y, Chen P, Li Z
Clin Transl Med. 2024; 14(2):e1558.
PMID: 38299307
PMC: 10831563.
DOI: 10.1002/ctm2.1558.
Reprogramming of pyrimidine nucleotide metabolism supports vigorous cell proliferation of normal and malignant T cells.
Watanabe T, Yamamoto Y, Kurahashi Y, Kawasoe K, Kidoguchi K, Ureshino H
Blood Adv. 2024; 8(6):1345-1358.
PMID: 38190613
PMC: 10945144.
DOI: 10.1182/bloodadvances.2023011131.
The Novel Link between Gene Expression Profiles of Adult T-Cell Leukemia/Lymphoma Patients' Peripheral Blood Lymphocytes and Ferroptosis Susceptibility.
Wang Y, Iha H
Genes (Basel). 2023; 14(11).
PMID: 38002949
PMC: 10671613.
DOI: 10.3390/genes14112005.
The transcriptome of HTLV-1-infected primary cells following reactivation reveals changes to host gene expression central to the proviral life cycle.
Aristodemou A, Rueda D, Taylor G, Bangham C
PLoS Pathog. 2023; 19(7):e1011494.
PMID: 37523412
PMC: 10431621.
DOI: 10.1371/journal.ppat.1011494.
Identification of miRnas with possible prognostic roles for HAM/TSP.
de Souza D, Pessoa R, Nukui Y, Pereira J, Marcusso R, de Oliveira A
Virulence. 2023; 14(1):2230015.
PMID: 37394816
PMC: 10321194.
DOI: 10.1080/21505594.2023.2230015.
HTLV-1 bZIP Factor-Induced Reprogramming of Lactate Metabolism and Epigenetic Status Promote Leukemic Cell Expansion.
Toyoda K, Yasunaga J, Shichijo T, Arima Y, Tsujita K, Tanaka A
Blood Cancer Discov. 2023; 4(5):374-393.
PMID: 37162520
PMC: 10473166.
DOI: 10.1158/2643-3230.BCD-22-0139.
Potential miRNA-gene interactions determining progression of various ATLL cancer subtypes after infection by HTLV-1 oncovirus.
Ghobadi M, Afsaneh E, Emamzadeh R, Soroush M
BMC Med Genomics. 2023; 16(1):62.
PMID: 36978083
PMC: 10045051.
DOI: 10.1186/s12920-023-01492-0.
Identification of novel miRNAs potentially involved in the pathogenesis of adult T-cell leukemia/lymphoma using WGCNA followed by RT-qPCR test of hub genes.
Shayeghpour A, Forghani-Ramandi M, Solouki S, Hosseini A, Hosseini P, Khodayar S
Infect Agent Cancer. 2023; 18(1):12.
PMID: 36841815
PMC: 9968414.
DOI: 10.1186/s13027-023-00492-0.
Viral, genetic, and immune factors in the oncogenesis of adult T-cell leukemia/lymphoma.
Yasunaga J
Int J Hematol. 2023; 117(4):504-511.
PMID: 36705848
DOI: 10.1007/s12185-023-03547-5.
Dual targeting of aberrant DNA and histone methylation synergistically suppresses tumor cell growth in ATL.
Kurahashi Y, Watanabe T, Yamamoto Y, Ureshino H, Kamachi K, Yoshida-Sakai N
Blood Adv. 2022; 7(8):1545-1559.
PMID: 36516085
PMC: 10130614.
DOI: 10.1182/bloodadvances.2022008362.
HTLV-1 persistence and leukemogenesis: A game of hide-and-seek with the host immune system.
Tan B, Sugata K, Ono M, Satou Y
Front Immunol. 2022; 13:991928.
PMID: 36300109
PMC: 9591123.
DOI: 10.3389/fimmu.2022.991928.